规格
|
Accession Number:
|
NM_005226.2 |
Assay Entry:
|
Cell-based beta-arrestin recruitment |
Cell Line:
|
U2OS |
Cell State:
|
Dividing Cells |
Cytoplasmic Tail:
|
Native Tail |
Druggable Target:
|
GPCRs |
Human Protein Class:
|
G-Protein Coupled Receptor (GPCR) |
Population Status:
|
Pool of Stable Cells |
Product Line:
|
Tango™ |
Readout:
|
End Point |
Reporter Gene:
|
BLA (Beta-Lactamase) |
System Type:
|
Tango™ |
Target Entry:
|
EDG3 |
Technique:
|
FRET |
Detection Method:
|
Fluorescent |
储存
|
Tango™ cell lines are shipped on dry ice. Store in liquid nitrogen immediately upon receipt, or thaw for immediate use. |
Tango™ EDG3-bla U2OS cells contain the human Endothelial Differentiation Gene 3 (EDG3) linked to a TEV protease site and a Gal4-VP16 transcription factor stably integrated into the Tango™ GPCR-bla U2OS parental cell line. This parental cell line stably expresses a beta-arrestin⁄TEV protease fusion protein and the beta-lactamase reporter gene under the control of a UAS response element. The Tango™ EDG3-bla U2OS cells have been functionally validated for Z’ factor and EC50 concentrations of S1P. In addition, Tango™ EDG3-bla U2OS cells have been tested for assay performance under variable conditions.